Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by country, state, or city

Search by locations

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Germany”

A Study to Test the Efficacy, Safety, and Tolerability of Bepranemab (UCB0107) in Patients With Mild Cognitive Impairment or Mild Alzheimer's Disease (AD)Completed
NCT04867616Phase 2Updated Jul 24, 2026
Sponsor: UCB Biopharma SRL
Alzheimer's Disease
United States, Belgium, Canada, France, Germany +5 more
HEARTBEAT-TROP. Polyethylene Glycol Precipitation to Unmask MacrotroponinRecruiting
NCT07726420NAUpdated Jul 24, 2026
Sponsor: Technical University of Munich
Diagnoses Disease
Germany
A Study of Acalabrutinib vs Investigator's Choice of Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in R/R CLLActive Not Recruiting
NCT02970318Phase 3Updated Jul 24, 2026
Sponsor: Acerta Pharma BV
Chronic Lymphocytic Leukemia
United States, Australia, Austria, Belgium, Bulgaria +20 more
BoStOn SCientific Rhythm MAnagemenT REgiStry (SOCRATES)Recruiting
NCT04823663N/AUpdated Jul 24, 2026
Sponsor: Boston Scientific Corporation
Cardiac Disease
Belgium, Canada, France, Germany, Greece +5 more
Phase 3 Study of MRTX849 With Cetuximab vs Chemotherapy in Patients With Advanced Colorectal Cancer With KRAS G12C Mutation (KRYSTAL-10)Active Not Recruiting
NCT04793958Phase 3Updated Jul 23, 2026
Sponsor: Mirati Therapeutics Inc.
Advanced Colorectal Cancer · Metastatic Colorectal Cancer
United States, Argentina, Australia, Austria, Belgium +27 more
Glycolytic Phenotype (vLapeak) and Magnitude of Skeletal Muscle Hypertrophy After Resistance TrainingRecruiting
NCT07721766NAUpdated Jul 23, 2026
Sponsor: Technical University of Munich
Healthy Volunteers · Muscle Hypertrophy · Glycolysis · Moderately Trainend
Finland, Germany, Ireland, Spain
Acyclovir in Ventilated Patients With Pneumonia and HSV-1 in BALRecruiting
NCT06134492Phase 3Updated Jul 23, 2026
Sponsor: Jena University Hospital
Pneumonia, Viral · Ventilator Associated Pneumonia · Community-acquired Pneumonia · Herpes Simplex
Germany
Rate of Progression in USH2A-related Retinal DegenerationActive Not Recruiting
NCT03146078N/AUpdated Jul 23, 2026
Sponsor: Jaeb Center for Health Research
Usher Syndrome, Type 2A · Retinitis Pigmentosa 39
United States, Canada, France, Germany, Netherlands +1 more
Colorectal Resections in Patients With Retroperitoneal SarcomaRecruiting
NCT06943612N/AUpdated Jul 23, 2026
Sponsor: Heidelberg University
Sarcoma, Soft Tissue · Retroperitoneal Sarcoma
Germany, Switzerland
Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Adolescent Stargardt DiseaseCompleted
NCT05244304Phase 3Updated Jul 23, 2026
Sponsor: Belite Bio, Inc
Stargardt Disease 1
United States, Australia, Belgium, China, France +6 more
Safety Study in Subjects ≥ 12 Years of Age With Hereditary Angioedema Switching to GaradacimabCompleted
NCT06806657Phase 4Updated Jul 23, 2026
Sponsor: CSL Behring
Hereditary Angioedema
United States, Canada, Germany
A Study Evaluating Rocatinlimab in Moderate-to-severe Atopic Dermatitis (ROCKET-IGNITE)Completed
NCT05398445Phase 3Updated Jul 23, 2026
Sponsor: Amgen
Atopic Dermatitis
United States, Argentina, Brazil, Canada, China +16 more
A Study of NT 201 in Adults With Moderate to Severe Platysma Prominence in Europe (PLATINUM EU)Active Not Recruiting
NCT07210463Phase 3Updated Jul 23, 2026
Sponsor: Merz Aesthetics GmbH
Neuromuscular Agents · Peripheral Nervous System Agents · Physiological Effects of Drugs · Acetylcholine Release Inhibitors
France, Germany, Poland, Spain
Pharmacokinetics of Bisoprolol and SGLT2i in Acutely Decompensated Heart FailureCompleted
NCT06453577N/AUpdated Jul 23, 2026
Sponsor: Universität des Saarlandes
Acute Decompensated Heart Failure
Germany
Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY)Active Not Recruiting
NCT05925803Phase 3Updated Jul 23, 2026
Sponsor: AstraZeneca
Systemic Sclerosis · Scleroderma
United States, Austria, Belgium, Canada, China +18 more
Wearable Blood-Pressure Monitoring Comparison StudyNot Yet Recruiting
NCT07719660N/AUpdated Jul 23, 2026
Sponsor: Technische Universität Dresden
Hypertension · Blood Pressure Monitoring · Wearable Devices · Photoplethysmography
Germany, Italy
A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple SclerosisActive Not Recruiting
NCT03523858Phase 3Updated Jul 23, 2026
Sponsor: Hoffmann-La Roche
Progressive Multiple Sclerosis (PMS)
United States, Bosnia and Herzegovina, Brazil, Canada, Colombia +19 more
A Rollover Study Evaluating Sotorasib With or Without Panitumumab in Participants With KRAS p.G12C MutationRecruiting
NCT07172919Phase 2Updated Jul 23, 2026
Sponsor: Amgen
Advanced Solid Tumors
United States, Australia, France, Germany, Greece +4 more
A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung CancerActive Not Recruiting
NCT06012435Phase 3Updated Jul 23, 2026
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Carcinoma, Non-Small-Cell Lung
United States, Argentina, Australia, Austria, Belgium +20 more
Digital Dementia Registry Bavaria (digiDEM Bayern): a Multicentre, Prospective, Longitudinal Register Study Including People With Mild Cognitive Impairment and Dementia as Well as Their Family CaregiversRecruiting
NCT07721701N/AUpdated Jul 23, 2026
Sponsor: University of Erlangen-Nürnberg Medical School
Mild Cognitive Disorder · Alzheimer Disease · Vascular Dementia · Dementia in Other Diseases Classified Elsewhere
Germany
PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALSRecruiting
NCT07142291Phase 2Updated Jul 23, 2026
Sponsor: PhenoNet, Inc.
Amyotrophic Lateral Sclerosis (ALS)
United States, Czechia, Germany, Poland, Serbia +1 more
Re-Radiochemotherapy and Pembrolizumab vs. Immuno(Chemo)Therapy for Locoregionally Recurrent PD-L1 Positive (CPS≥1) HNSCCRecruiting
NCT07026474Phase 3Updated Jul 23, 2026
Sponsor: Universität des Saarlandes
Recurrent Head and Neck Squamous Cell Carcinoma
Germany, Switzerland
EAST-1 (ERAP-inhibition in Axial Spondyloarthritis Trial - 1)Recruiting
NCT07047703Phase 1, Phase 2Updated Jul 23, 2026
Sponsor: Grey Wolf Therapeutics
Axial Spondyloarthritis (AxSpA)
Australia, Belgium, Germany, Netherlands, Poland +1 more
Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 MutationRecruiting
NCT07211958Phase 3Updated Jul 23, 2026
Sponsor: Syndax Pharmaceuticals
Acute Myeloid Leukemias
Australia, Austria, Belgium, Brazil, Canada +11 more
A Study to Learn More About How Well BAY3018250 Works and How Safe it is for People With Proximal Deep Vein ThrombosisCompleted
NCT06149520Phase 2Updated Jul 23, 2026
Sponsor: Bayer
Thrombolysis · Symptomatic Proximal Deep Vein Thrombosis
Belgium, Bulgaria, Canada, Czechia, France +8 more

Previous page Next page